Expression of E-cadherin and β-catenin is Altered at Tumor Budding Sites, Whose Number is Associated with the Progression of Colorectal Carcinoma
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background : Tumor budding is present in the stroma at the invasive margin of colorectal carcinomas (CRC). The disintegration of cell adhesion molecules is closely related to this process. This study investigated the role of tumor budding in the progression of CRC, and compared the expression of β-catenin and E-cadherin between tumor budding and tumor center to determine whether epithelial-to-mesenchymal transitions (EMTs) occur in tumor budding. Methods : The number of tumor budding (NTB) instances was determined in 58 cases of CRC, and immunoreactivities of E-cadherin and β-catenin were compared at the tumor center and at the tumor budding site. Immunohistochemical staining for vimentin was also done. Results : Tumor budding was seen in 52 tumors (90%). There were significant associations between NTB and cliniopathologic parameters such as tumor depth, nodal metastasis and clinical stage. Expression of cytoplasmic and nuclear β-catenin were significantly higher at tumor budding sites than in the tumor center. In contrast, expression of membranous and cytoplasmic E-cadherin were significantly higher in the tumor center than at the tumor budding sites. Vimentin was expressed at tumor budding foci of only 2 cases (3%). Conclusions : This study suggests that EMT occurs at tumor budding, and that NTB may be a good marker for predicting a poor prognosis in CRC.
Abstract
Background : Tumor budding is present in the stroma at the invasive margin of colorectal carcinomas (CRC). The disintegration of cell adhesion molecules is closely related to this process. This study investigated the role of tumor budding in the progression of CRC, and compared the expression of β-catenin and E-cadherin between tumor budding and tumor center to determine whether epithelial-to-mesenchymal transitions (EMTs) occur in tumor budding. Methods : The number of tumor budding (NTB) instances was determined in 58 cases of CRC, and immunoreactivities of E-cadherin and β-catenin were compared at the tumor center and at the tumor budding site. Immunohistochemical staining for vimentin was also done. Results : Tumor budding was seen in 52 tumors (90%). There were significant associations between NTB and cliniopathologic parameters such as tumor depth, nodal metastasis and clinical stage. Expression of cytoplasmic and nuclear β-catenin were significantly higher at tumor budding sites than in the tumor center. In contrast, expression of membranous and cytoplasmic E-cadherin were significantly higher in the tumor center than at the tumor budding sites. Vimentin was expressed at tumor budding foci of only 2 cases (3%). Conclusions : This study suggests that EMT occurs at tumor budding, and that NTB may be a good marker for predicting a poor prognosis in CRC.
참고문헌 (24)
- Ueno H, "Tumour ‘budding’as an index to estimate the potential of aggressiveness in rectal cancer", Histopathology, 40, pp.127~132 (2002)
- Morodomi T, "An index for estimating the probability of lymph node metastasis in rectal cancers: lymph node metastasis and the histopathology of actively invasive regions of cancer", Cancer, 63, pp.539~543 (1989)
- Masaki T, "Possible contribution of CD44 variant 6 and nuclear beta-catenin expression to the formation of budding tumor cells in patients with T1 colorectal carcinoma", Cancer, 92, pp.2539~2546 (2001)
- Park KJ, "Intensity of tumor budding and its prognostic implications in invasive colon carcinoma", Dis Colon Rectum, 48, pp.1597~1602 (2005)
- Horkko TT, "Budding invasive margin and prognosis in colorectal cancer: no direct association with beta-catenin expression", Eur J Cancer, 42, pp.964~971 (2006)
- Gabbert H, "Tumor dedifferentiation:an important step in tumor invasion", Clin Exp Metastasis, 3, pp.257~279 (1985)
- Thiery JP, "Epithelial-mesenchymal transitions in tumour progression", Nat Rev Cancer, 2, pp.442~454 (2002)
- Guarino M, "The role of epithelial-mesenchymal transition in cancer pathology", Pathology, 39, pp.305~318 (2007)
- Barth AI, "Cadherins, catenins and APC protein:interplay between cytoskeletal complexes and signaling pathways", Curr Opin Cell Biol, 9, pp.683~690 (1997)
- Korinek V, "Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-", - colon carcinoma, 1997, pp.275, 1784~1787
- Brembeck FH, "Balancing cell adhesion and Wnt signaling, the key role of beta-catenin", Curr Opin Genet Dev, 16, pp.51~59 (2006)
- Brabletz T, "beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer", Am J Pathol, 155, pp.1033~1038 (1999)
- Gradl D, "The Wnt", Wg signal transducer betacatenin controls fibronectin expression, 1999, pp.19, 5576~5587
- Wielenga VJ, "Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway", Am J Pathol, 154, pp.515~523 (1999)
- Mann B, "Target genes of beta-catenin-T cell-factor", lymphoid-enhancer-factor signaling in human colorectal carcinomas, 1999, 1603~1608
- Brabletz T, "Variable b-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment", Proc Natl Acad Sci, pp.10356~10361 (2001)
- Hlubek F, "Expression of the invasion factor laminin gamma2 in colorectal carcinomas is regulatedby beta-catenin", Cancer Res, 61, pp.8089~8093 (2001)
- Brabletz T, "Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front", Pathol Res Pract, 194, pp.701~704 (1998)
- Greene FL, "AJCC cancer staging manual" (2002), Springe-Verlag
- Imai T, "On metastasis of gastric carcinoma", Gan, 45, pp.213~216 (1954)
- Okuyama T, "Budding (sprouting) as a useful prognostic marker in colorectal mucinous carcinoma", Jpn J Clin Oncol, 32, pp.412~416 (2002)
- Bellovin DI, "Altered localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive disease", Cancer Res, 65, pp.10938~10945 (2005)
- Gosens MJ, "Loss of membranous Ep-CAM in budding colorectal carcinoma cells", Mod Pathol, 20, pp.221~232 (2007)
- Sordat I, "Tumor cell budding and laminin-5 expression in colorectal carcinoma can be modulated by the tissue micro-environment", Int J Cancer, 88, pp.708~717 (2000)